HealthEquity (NASDAQ:HQY) Raised to Buy at Wall Street Zen

HealthEquity (NASDAQ:HQY) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday.

A number of other brokerages have also commented on HQY. BTIG Research upped their price target on shares of HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Friday. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a research report on Monday, June 1st. KeyCorp restated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Citizens Jmp upped their target price on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. Finally, BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $85.00 to $105.00 in a research note on Thursday, April 9th. Eleven research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and an average price target of $110.93.

HealthEquity Trading Up 0.3%

HQY stock opened at $94.64 on Friday. HealthEquity has a one year low of $72.76 and a one year high of $105.96. The stock has a market cap of $7.91 billion, a price-to-earnings ratio of 35.45, a price-to-earnings-growth ratio of 1.59 and a beta of 0.21. The company has a fifty day moving average price of $90.21 and a two-hundred day moving average price of $84.94. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.13. The company had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts anticipate that HealthEquity will post 3.92 EPS for the current year.

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares in the company, valued at approximately $5,615,735. This represents a 5.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the transaction, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 17,905 shares of company stock worth $1,651,280. Corporate insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

A number of hedge funds and other institutional investors have recently made changes to their positions in HQY. Acumen Wealth Advisors LLC bought a new stake in shares of HealthEquity in the fourth quarter valued at approximately $27,000. Aster Capital Management DIFC Ltd bought a new position in HealthEquity during the 4th quarter worth $28,000. Caitong International Asset Management Co. Ltd increased its stake in HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares during the period. Leonteq Securities AG raised its holdings in HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC acquired a new position in HealthEquity in the 1st quarter valued at $33,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.